Clinical Trial Update: Treatment of Natural Killer/T Cell Lymphoma-I/II [Phase 4]

View source ↗

Summary

An update on a Phase 4 study evaluating treatment for extranodal natural killer/T-cell lymphoma, nasal type. The current trial status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extranodal Natural Killer T-cell Lymphoma Nasal Type

Snippet

Sponsor: Mingzhi Zhang | Conditions: Nasal and Nasal-type NK/T-cell Lymphoma | Phase 4 | Status: UNKNOWN